rs1555572239
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1_ModeratePM2PP5_Very_Strong
The NM_000088.4(COL1A1):c.3207+1G>C variant causes a splice donor, intron change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_000088.4 splice_donor, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
COL1A1 | NM_000088.4 | c.3207+1G>C | splice_donor_variant, intron_variant | Intron 43 of 50 | ENST00000225964.10 | NP_000079.2 | ||
COL1A1 | XM_011524341.2 | c.3009+1G>C | splice_donor_variant, intron_variant | Intron 40 of 47 | XP_011522643.1 | |||
COL1A1 | XM_005257058.5 | c.2937+1G>C | splice_donor_variant, intron_variant | Intron 41 of 48 | XP_005257115.2 | |||
COL1A1 | XM_005257059.5 | c.2289+1G>C | splice_donor_variant, intron_variant | Intron 30 of 37 | XP_005257116.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
COL1A1 | ENST00000225964.10 | c.3207+1G>C | splice_donor_variant, intron_variant | Intron 43 of 50 | 1 | NM_000088.4 | ENSP00000225964.6 | |||
COL1A1 | ENST00000486572.1 | n.26G>C | non_coding_transcript_exon_variant | Exon 1 of 2 | 3 | |||||
COL1A1 | ENST00000511732.1 | n.152G>C | non_coding_transcript_exon_variant | Exon 2 of 2 | 2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 34
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
COL1A1-related disorder Pathogenic:1
The COL1A1 c.3207+1G>C variant is predicted to disrupt the GT donor site and interfere with normal splicing. To our knowledge, this variant has not been reported in the literature or in a large population database (http://gnomad.broadinstitute.org), indicating it is rare. Variants that disrupt consensus splice donor sites in COL1A1 are expected to be pathogenic (Schleit et al. 2015. PubMed ID: 25963598). This variant is interpreted as likely pathogenic. -
Osteogenesis imperfecta type I Pathogenic:1
For these reasons, this variant has been classified as Pathogenic. Donor and acceptor splice site variants typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in COL1A1 are known to be pathogenic (PMID: 7942841, 9295084, 9443882). Experimental studies have shown that disruption of this splice site affects mRNA splicing (PMID:22565191). Disruption of this splice site has been observed in individuals and families with osteogenesis imperfecta (PMID:25963598, 22565191, 27509835). ClinVar contains an entry for this variant (Variation ID: 456764). This variant is not present in population databases (ExAC no frequency). This sequence change affects a donor splice site in intron 43 of the COL1A1 gene. It is expected to disrupt RNA splicing and likely results in an absent or disrupted protein product. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at